Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

The following is a summary of “Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe ...

Expert pulmonologists share essential guidelines on distinguishing normal coughs from dangerous ones, plus effective home ...

Until you have been through a health condition that sapped your energy, drained your pockets and made people hardly recognise ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

COPD is a syndrome akin to asthma but with important ... ACOS is beyond the scope of this article. However, a clinical definition is a necessary starting point for a review of potential ...

Paul Hudson - Chief Executive Officer Francois-Xavier Roger - Chief Financial Officer Houman Ashrafian - Executive Vice President and Head of Research and Development ...